Development of nongenotoxic hematopoietic stem cell transplantation regimens for fanconi anemia

Ended Project Grant Awarded Last action

Award ID
W81XWH2110262
Recipient
Awarding agency
Obligated
$519,702

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Palo Alto, CA 94305, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The Department of the Army Medical Command awarded a $519,702 Project Grant to Stanford University under the Military Medical Research and Development program (CFDA 12.420). The two-year grant will support Stanford's development of non-genotoxic hematopoietic stem cell transplantation regimens for Fanconi anemia. Fanconi anemia is a rare genetic disorder that can cause bone marrow failure and blood cancers. The Military Medical Research and Development program aims to advance medical solutions for service members and the public through innovative biomedical research. This award will fund Stanford's work to investigate new stem cell transplantation approaches without genotoxic risks for patients with Fanconi anemia. The research is expected to improve treatment options and outcomes for those suffering from this condition.

Quick answers

Who received award W81XWH2110262?

W81XWH2110262 was awarded to The Leland Stanford Junior University by Medical Command (Department of the Army) on September 1, 2021.

How much is award W81XWH2110262 worth?

$519,702 has been obligated on W81XWH2110262.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login